Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

BACKGROUND: The World Health Organization (WHO) recommends that the cost effectiveness of introducing human papillomavirus (HPV) vaccination is considered before such a strategy is implemented. However, developing countries often lack the technical capacity to perform and interpret results of econom...

Descripción completa

Detalles Bibliográficos
Autores principales: Jit, Mark, Demarteau, Nadia, Elbasha, Elamin, Ginsberg, Gary, Kim, Jane, Praditsitthikorn, Naiyana, Sinanovic, Edina, Hutubessy, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123559/
https://www.ncbi.nlm.nih.gov/pubmed/21569406
http://dx.doi.org/10.1186/1741-7015-9-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123559/
https://www.ncbi.nlm.nih.gov/pubmed/21569406
http://dx.doi.org/10.1186/1741-7015-9-54

Ejemplares similares